BioCentury
ARTICLE | Financial News

SymBio completes convertible bond financing

January 21, 2013 8:00 AM UTC

SymBio Pharmaceuticals Ltd. (JASDAQ:4582), Tokyo, Japan Business: Cancer, Gastrointestinal Date completed: 1/15/13 Type: Convertible bond financing Raised: ¥1 billion ($11.3 million) Shares outstandin...